Gelesis Holdings, Inc.
GLS
Rankning i aktier
#40616
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Aktiekurs
$0.0121
Senast synkroniserad: 2023-05-23
Marknadsvärde
$97.54K
Förändring (1 dag)
-24.38%
Förändring (1 år)
12,000.00%
Land
US
Handel Gelesis Holdings, Inc. (GLS)
Kategori
Healthcare
Aktiekurshistorik för Gelesis Holdings, Inc. (GLS)
Högsta slutkurs: $0.00 den 2026-10-01
Lägsta slutkurs: $9.82 den 2020-08-01
Lägsta slutkurs: $9.82 den 2020-08-01
Aktiekurshistorik för Gelesis Holdings, Inc. från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -12.13% |
| 2024 | -95.69% |
| 2023 | -99.13% |
| 2022 | -96.95% |
| 2021 | -0.60% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $534.84 | 25.42% |
US
|
|
| $189.00 | 603.91% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $888.12 | 9.08% |
NL
|
